April 30 - May 3, 2017
Manchester Grand Hyatt San Diego,
San Diego, CA
Build partnerships & accelerate products from early discovery to late-stage development & commercialization
Register for TIDES 2017
Early bird registration rates are now live for TIDES 2017! Start planning your team's trip now and take advantage of our lowest rates offered.
Call for Speakers - Deadline to Submit is October 14
We are currently accepting speaking proposals for TIDES 2017. If you would like to be considered for an oral podium presentation, please submit your proposal at the link below no later than October 14, 2016.
Speaking Inquiries: Contact Michael Keenan at michael.keenan@knect365.com
Start Planning Your Trip to TIDES 2017 in San Diego, CA
TIDES 2016 saw the largest attendance in its 18 year history, drawing more than 850 attendees from 25 countries around the globe. Attendees were able to apply learnings from 100+ case studies and new data presentations designed to help accelerate product development across the entire value chain from discovery, nonclinical, clinical and CMC to late-stage development and commercialization.
Our scientific advisory board is hard at work putting together another outstanding scientific program for 2017. Sign up for email updates below to stay up-to-date on program updates and registration offers!
Speak at TIDES 2017
Contact:
Michael Keenan
Conference Director
mkeenan@ibcusa.com
Become an Event Sponsor or Exhibitor
Contact:
Patrick Gallagher
Senior Sales Executive
pgallagher@ibcusa.com
+1-617-512-6656
Registration/Media/General Inquiries
Contact:
Howie Choi
Marketing Manager
hchoi@ibcusa.com
Attend the premier event for CMC, clinical, nonclinical and discovery scientists
850+
100+
70+
cross-fertilize ideas and best practices with researchers from different disciplines
TIDES offers separate tracks covering the latest oligonucleotide and peptide development strategies from discovery, nonclinical, clinical and CMC to late-stage development and commercialization.
Oligonucleotide Tracks
- Chemistry, Manufacturing & Controls Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.
- Discovery, Preclinical and Clinical Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.
Peptide Tracks
- Chemistry, Manufacturing & Controls Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.
- Discovery, Preclinical and Clinical Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.
Nonclinical Development of Oligonucleotides Track
- Case studies of nonclinical experiences and solutions including ADME/Tox problem-solving and support for lead programs as well as lessons learned from recent NDA reviews.
- Interactive discussions with expert panelists to overcome nonclinical safety issues and oligonucleotide development challenges.
Connect with Key Buyers at TIDES 2017 in San Diego, CA
Whether you're increasing your company profile, launching a new product or creating business development opportunities, we have flexible and tailored solutions that will optimize your investment. Contact Patrick Gallagher at (617) 512-6656 or email pgallagher@ibcusa.com for more information.